Stocktoria

HeartBeam, Inc. BEAT

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-10-14

HeartBeam, Inc. financials (annual)

Revenue
202020212022202320242025
Net income
-$1.1M -$4.4M -$13.0M -$14.6M -$19.4M -$21.0M 202020212022202320242025
Free cash flow
-$9.9M -$12.3M -$14.7M -$14.6M 202020212022202320242025

Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020
R&D expense$13.4M$11.1M$6.8M$5.7M$255,000$133,000
Operating income-$21.1M-$19.9M-$15.3M-$13.0M-$2.3M-$788,000
Interest expense————$2.2M$280,000
Income tax$0$0$0$0$0$0
Net income-$21.0M-$19.4M-$14.6M-$13.0M-$4.4M-$1.1M
EPS (diluted)$-0.62$-0.73$-0.72$-1.59$-1.03$-0.29
Operating cash flow-$14.0M-$14.5M-$12.1M-$9.9M-$3.2M-$600,000
Free cash flow-$14.6M-$14.7M-$12.3M-$9.9M——
Cash & equivalents$4.4M$2.4M$16.2M$3.6M$13.2M—
Inventory$103,000$0————
Total assets$5.8M$3.3M$17.1M$4.0M$14.0M$51,000
Total liabilities$3.2M$1.6M$1.2M$1.7M$588,000$4.8M
Shareholders' equity$2.6M$1.7M$15.9M$2.4M$13.4M-$4.8M

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.